US · guidance
CMS Pub. 100-18, ch. 6, § 30.3.2
Limitation of Formulary Changes Prior to Beginning of Contract Year
Except when the FDA deems a Part D drug unsafe or a manufacturer removes a Part D drug from
the market, a Part D sponsor may not remove a covered Part D drug from its formulary, or make
any change in preferred or tiered cost-sharing status of a covered Part D drug, between the
beginning of the annual coordinated election period described in section 42 CFR §423.38(b) and
60 days after the beginning of the contract year associated with the annual coordinated election
period.
History
(Rev. 18, Issued: 01-15-16, Effective: 01-15-16; Implementation: 01-15-16)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-09-17
- Edition
- iom-2026-09-17
- Content hash
d3432a628447398824420fe7f22ef34b7e57bf7e9c6002abc0754a0040f3beeb
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.